✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Shenzhen Hepalink Pharmaceutical Group Co Ltd

Common Name
Hepalink
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,150
Ticker
002399
Exchange
SHENZHEN STOCK EXCHANGE
Description
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is a prominent pharmaceutical company specializing in the production and distribution of heparin and related products. Heparin, a critical anticoagulan...

Disclosures of Hepalink

Explore Hepalink's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Hepalink's official channels and fully traceable to its official company sources.

The table below lists all of Hepalink's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20253 disclosures
Verification report
zh
Annual Report
enzh-Hant
ESG Report
en
20242 disclosures
Annual Report
enzh-Hant
ESG Report
enzh-Hant
20232 disclosures
ESG Report
en
Annual Report
enzh-Hant
20214 disclosures
Financial Report
Financial & Extra-Financial Disclosure
Annual Report
ESG Report
20204 disclosures
Financial & Extra-Financial Disclosure
Annual Report
Financial Report
ESG Report
20191 disclosure
Financial Report
20181 disclosure
Financial Report
20171 disclosure
Financial Report
20161 disclosure
Financial Report
20151 disclosure
Financial Report
20141 disclosure
Financial Report
20131 disclosure
Financial Report
20121 disclosure
Financial Report
20111 disclosure
Financial Report
20101 disclosure
Financial Report
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?